Related Experiment Video

Updated: Jun 21, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

Oligomycin induced the proteasomal degradation of cyclin D1 protein

Mai Kanai1, Satoru Iba, Ryoko Okada

  • 1Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Kohoku-ku, Yokohama, Japan.

The Journal of Antibiotics
|July 4, 2009
PubMed

Insights

Oligomycin, a natural compound, more effectively inhibits cancer cell growth when cyclin D1 is overexpressed. This inhibition involves reducing cyclin D1 protein levels through proteasomal degradation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • The cyclin D1/retinoblastoma protein pathway is crucial in cell cycle regulation and often dysregulated in cancer.
  • Identifying compounds that modulate this pathway is a key strategy for cancer therapy.

Purpose of the Study:

  • To screen for natural products that affect the cyclin D1/retinoblastoma protein pathway.
  • To investigate the mechanism by which effective compounds inhibit cancer cell growth.

Main Methods:

  • Utilized a Cre/loxP-regulated cyclin D1 overexpression system in SW480 cells via recombinant adenovirus.
  • Screened an in-house natural product library for compounds affecting the cyclin D1 pathway.
  • Assessed the effect of identified compounds on cell growth and cyclin D1 protein levels.

Main Results:

  • Oligomycin demonstrated enhanced inhibition of cell growth in cyclin D1-overexpressing SW480 cells compared to control cells.
  • Oligomycin treatment led to a reduction in cyclin D1 protein expression levels.
  • The reduction in cyclin D1 protein was found to be mediated, at least in part, by phosphorylation-dependent proteasomal degradation at Thr-286.

Conclusions:

  • Oligomycin exhibits potent anti-cancer activity, particularly in cells with elevated cyclin D1 levels.
  • The mechanism of oligomycin's action involves the targeted degradation of cyclin D1 protein.
  • This study identifies oligomycin as a potential therapeutic agent targeting the cyclin D1 pathway in cancer.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...